The top five tweets: From the FDA to Brexit — what rated top with EPM readers this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. Making it onto our top five list is the FDA approval of the first biosimilar for the treatment of certain breast and stomach cancers.

4. The survey results showing that Britain's manufacturers are enjoying export demand despite Brexit makes it into fourth position.

3. Third place goes to the news about written evidence on the impact of Brexit on pharma being published.

2. The collaboration between Oxford Genetics and MeiraGTx comes in second place.

1. Mylan joining in the fight for the prevention of HIV through PrEP is top of our list this week.